M-Form 850 mg (Tablet)

Unit Price: ৳ 5.50 (100's pack: ৳ 550.00)

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus
  • First-line therapy after diet failure for diabetic complications reduction
  • Monotherapy for adults
  • Combination therapy for adults
  • Monotherapy for children from 10 years of age and adolescents
  • Combination therapy for children and adolescents

Pharmacology

  • Biguanide type oral antihyperglycemic drug
  • Lowers basal and postprandial plasma glucose
  • Different mechanism of action from sulfonylureas
  • No hypoglycemia production
  • Decreases hepatic glucose production
  • Improves insulin sensitivity

Dosage & Administration

  • Individualized dosage based on effectiveness and tolerance
  • Usual starting dose of 500mg or 850mg
  • Dosage increases in increments of 500mg or 850mg
  • Maximum daily doses for adults and children
  • Extended release tablet instructions
  • Dosage adjustments for renal impaired patients

Interaction

  • No chronic co-administration information with Furosemide
  • Enhanced absorption with Nifedipine
  • Minimal effects on Nifedipine
  • Potential interaction with cationic drugs
  • No effect on Cimetidine pharmacokinetics
  • Drugs causing hyperglycemia and loss of glycemic control

Contraindications

  • Hypersensitivity to active substance or excipients
  • Acute metabolic acidosis
  • Severe renal failure
  • Conditions altering renal function
  • Conditions causing tissue hypoxia

Side Effects

  • Blood and lymphatic system disorders
  • Metabolism and nutrition disorders
  • Nervous system disorders
  • Gastrointestinal disorders
  • Hepatobiliary disorders
  • Skin and subcutaneous tissue disorders

Pregnancy & Lactation

  • Increased risk of congenital abnormalities and perinatal mortality
  • Uncontrolled diabetes during pregnancy
  • Recommended use of insulin during pregnancy
  • Excretion into human breast milk
  • Limited data available for breastfeeding

Precautions & Warnings

  • Substantially excreted by the kidney
  • Increased risk of lactic acidosis
  • Lowering of vitamin B12 level
  • Increased risk of hypoglycemia
  • Regular monitoring of renal function
  • Caution in elderly subjects

Use in Special Populations

  • Adjusted dosage for elderly subjects
  • Confirmation of type 2 diabetes mellitus before initiation
  • No effect on growth and puberty detected
  • Caution in prescribing to children aged 10-12 years
  • Creatinine clearance determination before treatment
  • Renal function assessment before and during treatment

Overdose Effects

  • Hypoglycemia with doses up to 85gm not seen
  • Occurrence of lactic acidosis in overdose
  • Treatment method for lactic acidosis

Therapeutic Class

  • Biguanides

Storage Conditions

  • Keep below 30°C temperature
  • Protected from light & moisture
  • Keep out of the reach of children

Related Brands